Your browser doesn't support javascript.
loading
Integrative genotyping of cancer and immune phenotypes by long-read sequencing.
Penter, Livius; Borji, Mehdi; Nagler, Adi; Lyu, Haoxiang; Lu, Wesley S; Cieri, Nicoletta; Maurer, Katie; Oliveira, Giacomo; Al'Khafaji, Aziz M; Garimella, Kiran V; Li, Shuqiang; Neuberg, Donna S; Ritz, Jerome; Soiffer, Robert J; Garcia, Jacqueline S; Livak, Kenneth J; Wu, Catherine J.
  • Penter L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Borji M; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.
  • Nagler A; Harvard Medical School, Boston, MA, USA.
  • Lyu H; Department of Hematology, Oncology, and Tumorimmunology, Campus Virchow Klinikum, Berlin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Lu WS; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, BIH Charité Digital Clinician Scientist Program, Charitéplatz 1, 10117, Berlin, Germany.
  • Cieri N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Maurer K; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.
  • Oliveira G; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Al'Khafaji AM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Garimella KV; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.
  • Li S; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Neuberg DS; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Ritz J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Soiffer RJ; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.
  • Garcia JS; Harvard Medical School, Boston, MA, USA.
  • Livak KJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Wu CJ; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.
Nat Commun ; 15(1): 32, 2024 01 02.
Article en En | MEDLINE | ID: mdl-38167262
ABSTRACT
Single-cell transcriptomics has become the definitive method for classifying cell types and states, and can be augmented with genotype information to improve cell lineage identification. Due to constraints of short-read sequencing, current methods to detect natural genetic barcodes often require cumbersome primer panels and early commitment to targets. Here we devise a flexible long-read sequencing workflow and analysis pipeline, termed nanoranger, that starts from intermediate single-cell cDNA libraries to detect cell lineage-defining features, including single-nucleotide variants, fusion genes, isoforms, sequences of chimeric antigen and TCRs. Through systematic analysis of these classes of natural 'barcodes', we define the optimal targets for nanoranger, namely those loci close to the 5' end of highly expressed genes with transcript lengths shorter than 4 kB. As proof-of-concept, we apply nanoranger to longitudinal tracking of subclones of acute myeloid leukemia (AML) and describe the heterogeneous isoform landscape of thousands of marrow-infiltrating immune cells. We propose that enhanced cellular genotyping using nanoranger can improve the tracking of single-cell tumor and immune cell co-evolution.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Secuenciación de Nucleótidos de Alto Rendimiento Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Secuenciación de Nucleótidos de Alto Rendimiento Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article